Top Markets
#1 Black Phoenix Black Phoenix +742.50%
#2 Beam Beam +45.75%
#3 THORChain THORChain +19.76%
#4 SAFEcoin SAFEcoin +17.86%
#5 TENDIES TENDIES +17.26%
#6 Bless Bless +16.36%
#7 MiL.k Alliance MiL.k Alliance +16.34%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.76%
#9 THORChain Yield THORChain Yield +14.89%
#10 EfficientFrontier EfficientFrontier +14.52%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Rank in Stocks #5577
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Share Price
$36.98
Last synced: 2026-08-26
Market Cap
$2.58B
Change (1 day)
-0.67%
Change (1 year)
55.51%
Country
NL
Trade Pharvaris N.V. (PHVS)

Category

Healthcare
Stock price history for Pharvaris N.V. (PHVS)
Highest end of day price: $35.74 on 2026-08-01

Lowest end of day price: $31.41 on 2021-02-01
Stock price history of Pharvaris N.V. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 9.05%
2025 33.94%
2024 -24.64%
2023 230.41%
2022 -49.99%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $760.57 6.54%
CH